SCHEMBL15569123

SCHEMBL15569123

COc1ccc(S(=O)(=O)NC2CCN(c3nc4ccccc4n3Cc3cccc(F)c3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 11/20 0.53
▸ CYP2D6 P10635 10/20 0.53
▸ KCNH2 Q12809 8/20 0.53
▸ CHRM1 P11229 4/20 0.52
▸ HTR3A P46098 2/20 0.51
▸ SSTR5 P35346 2/20 0.49
▸ CCR3 P51677 1/20 0.47
▸ HSD11B1 P28845 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ EED O75530 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ MLNR O43193 1/20 0.46
▸ CACNA1F O60840 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ ABCB11 O95342 1/20 0.46
▸ EGFR P00533 1/20 0.46
▸ HLA-A P04439 1/20 0.46
▸ ERBB2 P04626 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15567781 0.86 HRH1 (0.55) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15568150 0.84 HRH1 (0.55) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15568638 0.84 HRH1 (0.50) HRH1CYP2D6KCNH2CHRM1CCR3
SCHEMBL15567224 0.83 HRH1 (0.55) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15569414 0.83 HRH1 (0.56) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15568411 0.82 HRH1 (0.48) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15567917 0.81 HRH1 (0.62) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15568550 0.81 HRH1 (0.55) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15568004 0.81 HRH1 (0.51) HRH1CYP2D6KCNH2CHRM1HTR3A
SCHEMBL15567597 0.80 HRH1 (0.54) HRH1CYP2D6KCNH2CHRM1HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO disclosed
Send feedback